E. Maser

发表

Gut microbiota density influences host physiology and is shaped by host and microbial factors

Judy H. Cho, K. Hao, A. Kasarskis, 2018, bioRxiv.

Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.

M. Silverberg, G. Greenberg, E. Maser, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.

A. Kornbluth, D. Present, T. Ullman, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Abstracts of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation

J. Makanyanga, A. Kornbluth, R. Mountifield, 2021 .

Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical Home

M. Dubinsky, B. Sands, L. Keefer, 2021, Journal of pharmacy practice.

W1105 Cyclosporine and Infliximab As Delayed Salvage Therapy for Each Other in Patients with Steroid-Refractory Ulcerative Colitis

A. Kornbluth, D. Present, T. Ullman, 2009 .

Management of Hospitalized Patient with Ulcerative Colitis Refractory to Corticosteroids

E. Maser, L. Rabinowitz, S. Gold, 2021, Management of Inpatient Inflammatory Bowel Disease.

Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.

Eun Soo Kim, M. Dubinsky, A. Kornbluth, 2020, Gastroenterology.

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

J. Clemente, J. Faith, I. Mogno, 2019, Gut.